Home
About
Overview
Sharing Data
ORCID
Help
History (2)
Japanese regulatory authority's perspective on biosimilars - authors' reply.
Myeloid growth factors. Clinical practice guidelines in oncology.
See All 2 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Japanese regulatory authority's perspective on biosimilars - authors' reply.
Japanese regulatory authority's perspective on biosimilars - authors' reply. Lancet Oncol. 2015 Mar; 16(3):e102.
View in:
PubMed
subject areas
Antineoplastic Agents
Biosimilar Pharmaceuticals
Drug Approval
Humans
Neoplasms
authors with profiles
Charles Lee Bennett